One subscription. Unlimited analyses.

Unlimited terminal analyses on any US, CA (TSX), UK, EU, or JP equity. Portfolio — build a scenario-weighted long-horizon portfolio from your saved analyses, project its value at 10 or 20 years, and track daily prices across all positions. Full access to Chosen Weekly Stocks. Dashboard storage for all your past analyses. PDF export of every report.

Because every analysis AMORDAD runs is genuinely expensive to produce — and we refused to compromise on what "expensive" buys you. Each analysis pulls live market data, runs deep web research across regulatory filings and material news, processes your ticker through six investor frameworks simultaneously, builds a full DCF with three scenarios, executes an eight-scenario stress test, and writes a 700-word Buffett-tradition letter — all in under two minutes. That depth costs real money in compute and API fees per run. A lesser product would cap costs by degrading the research quality, skipping the live data layer, or reducing the number of analytical lenses. We chose not to. The 15-analysis monthly limit is the honest result of doing the math: at $39/month, 15 full-depth runs is what lets us keep every analysis at institutional grade without cutting corners. For context, a single Bloomberg terminal costs over $2,000 per month and still requires a human analyst to synthesise the output. Fifteen AMORDAD analyses, each synthesised across six investor philosophies, represents more structured analytical depth than most portfolio managers produce in a month.

Because the work is real. When you submit a ticker, AMORDAD does not retrieve a pre-built report — it conducts a live, original analysis from scratch. That means pulling current market data, reading through recent regulatory filings and material news, running the ticker through six distinct investor frameworks simultaneously, building a full discounted cash flow model with three scenarios, stress-testing the business across eight adverse situations, and composing a 700-word institutional letter — all in a single session. The depth of that process is what makes the output genuinely useful rather than generic. A superficial screener takes three seconds because it does three seconds worth of work. AMORDAD takes up to seven minutes because it is doing the kind of structured, multi-lens research that would take a professional analyst the better part of a morning. The wait is the quality.

Yes. There is no commitment. You can cancel a monthly subscription at any time and retain access through the end of the billing period. Annual subscribers are covered by the thirty-day money-back guarantee.

Yes. Your first analysis is free. No credit card is required. You will receive a complete six-investor verdict, the Buffett-tradition letter, and a PDF export — the full product on a single ticker.

Monthly subscriptions are billed on a rolling 30-day cycle. Annual subscriptions are billed once per year. We accept all major credit and debit cards through Stripe. We do not store your card information directly.

Not yet. We are focused on the individual analyst — the family-office associate, the portfolio manager, the serious retail investor. Team plans are on the roadmap; if your firm is interested, write to us at Parham@amordad.capital.

All major credit and debit cards (Visa, Mastercard, American Express, Discover). Apple Pay and Google Pay on supported devices. We do not currently accept cryptocurrency, wire transfer, or invoice billing.

No. AMORDAD is a research and analysis tool. The output is educational. Nothing AMORDAD generates constitutes a recommendation to buy, sell, or hold any security. The decisions are yours; the research is ours.

Your watchlists and analysis history are encrypted at rest. We do not sell your data. We do not share your data with advertisers. We collect only what is necessary to operate the service.